Yutong Zhu

Pamiparib is a potent and selective PARP inhibitor with unique potential for the treatment of brain tumor

Yao Xiong, Yin Guo, Ye Liu et al. · Neoplasia · 2020 · 98 citations · Full text

Medicine, Oncology, Pharmacology +17

Discovery of Pamiparib (BGB-290), a Potent and Selective Poly (ADP-ribose) Polymerase (PARP) Inhibitor in Clinical Development

Hexiang Wang, Bo Ren, Ye Liu et al. · Journal of Medicinal Chemistry · 2020 · 78 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Sonrotoclax overcomes BCL2 G101V mutation–induced venetoclax resistance in preclinical models of hematologic malignancy

Jiuyang Liu, Shuran Li, Qin Wang et al. · Blood · 2024 · 71 citations · Full text

Medicine, Oncology, Pharmacology +15

Discovery of the Clinical Candidate Sonrotoclax (BGB-11417), a Highly Potent and Selective Inhibitor for Both WT and G101V Mutant Bcl-2

Yunhang Guo, Yunhang Guo, Hai Xue et al. · Journal of Medicinal Chemistry · 2024 · 42 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

[Effect of anti-influenza virus of Arctigenin in vivo].

Zifeng Yang, Ni Liu, Bi-Song Huang et al. · PubMed · 2005 · 23 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17